LOADING
Comparing Coca-Cola Company (KO) and Pfizer Inc (PFE) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | KO | PFE |
|---|---|---|
| Price | $80.45 | $25.75 |
| Change Today | +0.24% | -0.81% |
| Market Cap | $345.3B | $148.0B |
| P/E Ratio | 25.2 | 19.8 |
| Forward P/E | 24.1 | 8.8 |
| PEG Ratio | 4.01 | 13.77 |
| EPS | $3.19 | $1.31 |
| Revenue Growth (YoY) | 12.1% | 5.4% |
| Profit Margin | 27.8% | 11.8% |
| Return on Equity | 43.4% | 8.3% |
| Dividend Yield | 2.57% | 6.65% |
| Beta | 0.36 | 0.30 |
| 52-Week High | $81.44 | $28.28 |
| 52-Week Low | $64.45 | $20.98 |
| Volume | 10.6M | 24.1M |
Coca-Cola Company is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.